The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Analysis of “double-hit” lymphoma cases by genetic subtype.
 
Daniel Jeffrey Landsburg
No Relationships to Disclose
 
Adam Matthew Petrich
No Relationships to Disclose
 
Jeremy S. Abramson
No Relationships to Disclose
 
Aliyah Sohani
No Relationships to Disclose
 
Oliver W. Press
Stock and Other Ownership Interests - Emergent Biosolutions; PhaseRx
Consulting or Advisory Role - Adaptive Biotechnologies; Algeta ASA; BIND Biosciences; Roche
Research Funding - Genentech (Inst); Presage Biosciences (Inst)
Travel, Accommodations, Expenses - Algeta ASA; Roche
 
Ryan Daniel Cassaday
No Relationships to Disclose
 
Julio C. Chavez
No Relationships to Disclose
 
Kevin W. Song
Research Funding - Roche Canada
 
Andrew David Zelenetz
Honoraria - Celgene; Gilead Sciences
Consulting or Advisory Role - Alissa Pharma; Amgen; Dr. Reddy's Laboratories; Genentech/Roche; Gilead Sciences; Hospira
Research Funding - Bristol-Myers Squibb; Genentech/Roche; Gilead Sciences
Travel, Accommodations, Expenses - Celgene; Kirin Pharmaceuticals
Other Relationship - Boehringer Ingelheim
 
Mitul Gandhi
No Relationships to Disclose
 
Namrata Mahendra Shah
No Relationships to Disclose
 
Timothy Fenske
No Relationships to Disclose
 
Jesse Jasso
No Relationships to Disclose
 
L Jeffrey Medeiros
No Relationships to Disclose
 
David T Yang
No Relationships to Disclose
 
Chadi Nabhan
Consulting or Advisory Role - Celgene; Genentech; Janssen Oncology; Medivation
Research Funding - Celgene; Genentech; Medivation